Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial

BACKGROUND: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure. Although angiotensin II receptor blockers (ARBs) can be used to attenuate proteinuria in DN patients, their efficacy remains limited. This clinical trial aimed to evaluate the efficacy of Tripterygium wilfordi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yongchun, Xie, Honglang, Li, Shijun, Jin, Bo, Hou, Jinhua, Zhang, Haitao, Shi, Mingjun, Liu, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670993/
https://www.ncbi.nlm.nih.gov/pubmed/23725518
http://dx.doi.org/10.1186/1479-5876-11-134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670993/
https://www.ncbi.nlm.nih.gov/pubmed/23725518
http://dx.doi.org/10.1186/1479-5876-11-134

Ejemplares similares